{
    "identity": "pex-1149",
    "title": "<p>Synthesis of T785</p>",
    "content": [
        {
            "header": "Introduction",
            "content": "<p>T785 was prepared via an eight step synthesis starting from commercially available starting materials.&nbsp;Commercially available 3-nitroquinoline-2,4-diol undergoes nitration and chlorination followed by a regioselective addition of tert-butyl N-(4-aminobutyl)carbamate.&nbsp;Aniline formation via hydrogenation and subsequent acylation undergoes imidazoquinoline ring formation under acidic conditions.&nbsp;Finally, displacement of the chloroquinoline by (2,4-dimethoxyphenyl)methanamine and acidic deptrotection yields T785 in ~36% overall yield.&nbsp;</p>"
        },
        {
            "header": "Reagents",
            "content": "<p>Acetic acid</p><p>Nitric Acid</p><p>POCl3</p><p>Pet ether</p><p>ethyl acetate</p><p>water</p><p>THF</p><p>Triethylamine</p><p>Pt/C</p><p>Nitrogen gas</p><p>pentanoyl chloride</p><p>Sodium sulfate (Na2SO4)</p><p>MeOD</p><p>d-DMSO</p><p>NaHCO3</p><p>HCl</p><p>MeOH</p><p>quinoline-2,4-diol</p><p>tert-butyl N-(4-aminobutyl)carbamate</p><p>(2,4-dimethoxyphenyl)methanamine</p>"
        },
        {
            "header": "Equipment",
            "content": "<p>Rotoevaporary</p><p>Flask</p><p>Seperatory funnel</p><p>Stir plate</p><p>NMR</p><p>Thin Layer Chromotagraphy</p><p>HPLC</p><p>LCMS</p>"
        },
        {
            "header": "Procedure",
            "content": "3-nitroquinoline-2,4-diol (\n1\n).\u00a0To a solution of quinoline-2,4-diol (260 g, 1.61 mol, 1 eq) in AcOH (1.2 L) is added fuming nitric acid (152.49 g, 2.42 mol, 108.92 mL, 1.5 eq) dropwise at 0\u00b0C.\u00a0The mixture is stirred at 65\u00b0C for 5 hours. The mixture is cooled to 25\u00b0C and quenched by the addition of ice-water (500 mL). The product is separated\u00a0by\u00a0filtration and washed with water (500 mL x 3), and dried to give 3-nitroquinoline-2,4-diol (320 g, 1.52 mol, 94.29%\u00a0yield) as\u00a0yellow solid.\u00a0\u00a0\u00a0The crude product was used in the next step without further purification. LC/MS:\u00a0\u00a0m/z = 207.0 [M+H]\n+\n1H NMR (DMSO-d\n6\n, 400 MHz) \u03b4 11.96 (s, 1H), 8.04 (d, J = 8.0 Hz, 1H), 7.64 (t, J = 7.2 Hz,1H), 7.34 (d, J = 8.0 Hz, 1H), 7.27 (t, J = 7.2 Hz, 1H).\n2,4-dichloro-3-nitroquinoline (\n2\n).\u00a03-nitroquinoline-2,4-diol (365 g, 1.77 mol, 1 eq) is added slowly to POCl\n3\n(2.44 kg, 15.93 mol, 1.48 L, 9 eq) at 65\u00b0C and further heated to 90\u00b0C for 12 h. The mixture is concentrated under vacuum.\u00a0The residue is then poured into ice-water (3 L) and stirred for an additional 0.5 h. The aqueous phase is filtered, washed by water (500 mL x 5) and the filter cake is collected and further purified by silica gel chromatography (Petroleum ether/Ethyl acetate=20/1, 3/1) to obtain 2,4-dichloro-3-nitro-quinoline (330 g, 1.32 mol, 74.39% yield, 97% purity) as yellow solid. LC/MS: m/z = 243.0 [M+H]\n+\n1H NMR (CDCl\n3\n, 400 MHz) \u03b4 8.29 (d, J = 8.4 Hz, 1H), 8.13 (d, J = 8.4 Hz, 1H), 7.96 (t, J =8.4 Hz, 1H), 7.82 (t, J = 8.4 Hz, 1H).\nTert-butyl N-[4-[(2-chloro-3-nitro-4-quinolyl) amino]butyl]carbamate (\n3\n).\u00a0\u00a0To a mixture of 2,4-dichloro-3-nitro-quinoline (330 g, 1.36 mol, 1 eq) and tert-butyl N-(4-aminobutyl)carbamate (281.18 g, 1.49 mol, 1.1 eq) in THF (1.5 L) is added Et\n3\nN (206.09 g, 2.04 mol, 283.48 mL, 1.5 eq) slowly at 0\u00b0C and stirred for 2 h. TLC (Petroleum ether: Ethyl acetate = 1:1, Rf = 0.43) showed the starting materials is consumed completely and one main spot is detected. The reaction is quenched by water (2 L) and extracted\u00a0with EtOAc (800 mL x 3).\u00a0The combined organic layer is washed by brine (1000 mL), dried over Na\n2\nSO\n4\n, filtered, and concentrated in vacuum. The crude product is washed by petroleum ether (1000 mL) and filtered to give tert-butyl N-[4-[(2-chloro-3-nitro-4-quinolyl) amino]butyl]carbamate (500 g, crude) as yellow solid. LC/MS:\u00a0m/z = 395.2 [M+H]\n+\n1H NMR (CDCl\n3\n, 400 MHz) \u03b4 8.12 (d, J = 7.2 Hz, 1H), 7.92 (d, J = 8.4 Hz, 1H), 7.75 (t, J =7.2 Hz, 1H), 7.53 (t, J = 7.6 Hz, 1H), 6.43 (s, 1H), 4.70 (s, 1H), 3.50-3.45 (m, 2H), 3.22-3.17(m, 2H), 1.80-1.75 (m, 2H), 1.67-1.61 (m, 2H), 1.44 (s, 9H).\nTert-butyl N-[4-[(3-amino-2-chloro-4-quinolyl)amino]butyl]carbamate (\n4\n).\u00a0To a solution of tert-butyl N-[4-[(2-chloro-3-nitro-4-quinolyl)amino]butyl]carbamate (150 g, 379.89 mmol, 1 eq) in EtOAc (800 mL) is added Pt/C (40 g, 10% purity) under N\n2\n. The suspension was degassed under vacuum and purged with H\n2\nseveral times. The mixture was stirred under H\n2\n(50 psi) at 25\u00b0C for 3 hours. LCMS and HPLC showed the starting material is consumed completely. The reaction mixture was filtered and the filtrate is concentrated to give tert-butyl N-[4-[(3-amino-2-chloro-4-quinolyl)amino]butyl]carbamate (110 g, crude) as an off-white solid. LC/MS:\u00a0m/z = 365.2 [M+H]\n+\n1H NMR (CDCl\n3\n, 400 MHz) \u03b4 7.90 (d, J = 8.0 Hz, 1H), 7.79 (d, J = 7.6 Hz, 1H) 7.49-7.45 (m,2H), 4.59 (s, 1H), 4.15-4.10 (m, 2H), 3.29-3.26 (m, 2H), 3.18-3.16 (m, 2H), 1.70-1.60 (m, 4H), 1.45 (s, 9H).\nTert-butyl N-[4-[[2-chloro-3-(pentanoylamino)-4-quinolyl]amino]butyl] carbamate (\n5\n). To a mixture of tert-butyl N-[4-[(3-amino-2-chloro-4-quinolyl)amino]butyl] carbamate (500 g, 1.37 mol, 1 eq) and Et\n3\nN (208.00 g, 2.06 mol, 286.11 mL, 1.5 eq) in THF (1000 mL) is added\u00a0pentanoyl\u00a0chloride\u00a0(247.85\u00a0g,\u00a02.06\u00a0mol,\u00a0249.10\u00a0mL,\u00a01.5\u00a0eq)\u00a0dropwise\u00a0at\u00a00\u00b0C.\u00a0\u00a0\u00a0The mixture is stirred at 0\u00b0C for 1 h. The mixture is poured into ice water (1000 mL) and stirred for 2 min. The aqueous phase is extracted with ethyl acetate (500 mL x 3).\u00a0The combined organic phase was washed with brine (1000 mL), dried with anhydrous Na\n2\nSO\n4\n, filtered and concentrated in vacuum. The residue is purified by re-crystallization from EtOAc/petroleum ether (1/1, 800 mL) to give the pure tert-butyl N-[4-[[2-chloro-3-(pentanoylamino)-4-quinolyl]amino] butyl] carbamate (550 g, 1.16 mol, 84.92% yield, 95% purity) as light yellow solid. LC/MS:\u00a0m/z = 449.3 [M+H]\n+\n1H NMR (MeOD, 400 MHz) \u03b4 8.14 (d, J = 8.4 Hz, 1H), 7.72 (d, J = 7.6 Hz, 1H), 7.67 (t, J = 8.0 Hz, 1H), 7.46 (t, J = 6.8 Hz, 1H), 3.56 (t, J = 7.2 Hz, 2H), 3.07 (t, J = 7.2 Hz, 2H), 2.51 (t, J = 7.6 Hz, 2H), 1.77-1.66 (m, 4H), 1.54-1.41 (m, 4H), 1.41 (s, 9H), 1.01 (t, J = 7.2 Hz, 3H).\nTert-butyl N-[4-(2-butyl-4-chloro-imidazo[4,5-c]quinolin-1-yl)butyl]carbamate (\n6\n).\u00a0To a solution of tert-butyl N-[4-[[2-chloro-3-(pentanoylamino)-4-quinolyl]amino] butyl]carbamate (490 g, 1.09 mol, 1 eq) in toluene (1000 mL) is added AcOH (65.54 g, 1.09 mol, 62.42 mL, 1 eq) at 25\u00b0C. The mixture is stirred at\u00a0100\u00b0C\u00a0for\u00a015\u00a0hours. The mixture is concentrated in vacuum.\u00a0The residue is poured into ice water (1000 mL) and stirred for 5 min. The aqueous phase is extracted with ethyl acetate (500 mL x 3). The combined organic phase is washed with NaHCO\n3\n.aq (500 mL) and brine (800 mL), dried with anhydrous Na\n2\nSO\n4\n, filtered and concentrated in vacuum. The residue is purified by re-crystallized from EtOAc/ petroleum ether (1/50, 500 mL) to give tert-butyl N-[4-(2-butyl-4-chloro-imidazo[4,5-c]quinolin-1- yl)butyl]carbamate (400 g, 928.14 mmol, 85.05% yield) as a white solid. LC/MS:\u00a0m/z = 431.1 [M+H]\n+\n1H NMR (CDCl\n3\n, 400 MHz) \u03b4 8.19 (d, J = 6.8 Hz, 1H), 8.09 (d, J = 7.6 Hz, 1H) 7.66-7.62 (m,2H), 4.61\u00a0(s,\u00a01H),\u00a04.54\u00a0(t,\u00a0J = 7.6\u00a0Hz,\u00a02H),\u00a03.21-2.20\u00a0(m,\u00a02H),\u00a03.00\u00a0(t,\u00a0J = 8.0\u00a0Hz, 2H), 1.97-1.88 (m, 4H), 1.71-1.69 (m, 2H), 1.55-1.49 (m, 2H), 1.42 (s, 9H), 1.01 (t, J = 7.2 Hz, 3H).\nTert-butyl N-[4-[2-butyl-4-[(2,4-dimethoxyphenyl)methylamino]imidazo[4,5-c]quinolin-1-yl]butyl]carbamate (\n7\n).\u00a0\u00a0Tert-butyl N-[4-(2-butyl-4-chloro-imidazo[4,5-c]quinolin-1-yl)butyl] carbamate (62 g, 143.86mmol, 1 eq) in (2,4-dimethoxyphenyl)methanamine (120.27 g, 719.31 mmol, 108.35 mL, 5 eq) is stirred at 120\u00b0C for 3 hr.\u00a0LCMS showed the reaction is completed.\u00a0The reaction is quenched by addition of water (200 mL), acidified by diluted hydrochloride acid and extracted with\u00a0EtOAc\u00a0(300 mL x 3).\u00a0The combined organic layers is washed by brine (500 mL), dried over Na\n2\nSO\n4\n, filtered and concentrated under reduced pressure. The residue is purified by re-crystallization from\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0EtOAc (200mL) to give tert-butyl N-[4-[2-butyl-4-[(2,4-dimethoxyphenyl)methylamino]imidazo[4,5-c]quinolin-1-yl]butyl]carba mate (70 g, 118.39 mmol, 82.29% yield, 95% purity) as white solid. LC/MS:\u00a0m/z = 562.4 [M+H]\n+\n1H NMR (MeOD, 400 MHz) \u03b4 8.22 (d, J = 8.4 Hz, 1H), 8.05 (s, 1H), 7.74 (t, J = 7.6 Hz, 1H),7.66 (t, J = 8.4 Hz, 1H), 7.31 (d, J = 8.4 Hz, 1H), 6.63-6.58 (m, 1H), 6.54 (d, J = 8.0 Hz, 1H) 4.62 (t, J = 7.2 Hz, 2H), 3.82 (s, 3H), 3.79 (s, 3H), 3.12 (t, J = 6.8 Hz, 2H), 3.00 (t, J = 7.6 Hz, 2H), 1.98-1.86 (m, 4H), 1.69-1.65 (m, 2H ), 1.53-1.50 (m, 2H), 1.37 (s, 9H), 1.01 (t, J = 7.6 Hz,\n1-(4-aminobutyl)-2-butyl-imidazo[4,5-c]quinolin-4-amine (\n9\n).\u00a0Tert-butyl N-[4-[2-butyl-4-[(2,4-dimethoxyphenyl)methylamino]imidazo[4,5-c] quinolin-1-yl] butyl]carbamate (30 g, 53.41 mmol, 1 eq) is added to HCl (12M, 200 mL) at 25\u00b0C. The mixture is stirred at 25\u00b0C for 12 hour. LCMS showed the starting material is consumed completely. The reaction mixture is filtered, washed with MeOH (500 mL) and the filtrate is concentrated to give the crude product, recrystallized from EtOAc (50 mL) to give the pure 1-(4-aminobutyl)-2-butyl-imidazo[4,5-c]quinolin-4-amine (17 g, 48.38 mmol, 90.58% yield, 99% purity, HCl) as white solid. 1H NMR (MeOD, 400 MHz) \u03b4 8.28 (d, J = 7.6 Hz, 1H), 7.82 (d, J = 8.4 Hz, 1H), 7.75 (t, J =7.6 Hz, 1H), 7.76 (t, J = 7.6 Hz, 1H), 4.72 (t, J = 7.6 Hz, 2H), 3.08 (t, J = 7.6 Hz, 2H), 3.01 (t, J = 7.6 Hz, 2H), 2.07-1.85 (m, 6H), 1.62-1.53 (m, 2H), 1.05 (t, J = 7.6 Hz, 3H). LCMS (ESI): [M+H]\n+\n. calculated 312.21, [M+H]\n+\nfound 312."
        }
    ],
    "attributes": {
        "acceptedTermsAndConditions": true,
        "allowDirectSubmit": true,
        "archivedVersions": [],
        "articleType": "Method Article",
        "associatedPublications": [
            {
                "doi": "10.1038.s43018-020-00136-x",
                "date": "",
                "title": "",
                "authors": "",
                "journal": "",
                "logo": ""
            }
        ],
        "authors": [
            {
                "id": 2500883,
                "identity": "346a06ec-6fd1-43cd-88ad-db03b24688d4",
                "order_by": 0,
                "name": "Brian Safina",
                "email": "bsafina@boltbio.com",
                "orcid": "",
                "institution": "Bolt Biotherapeutics",
                "correspondingAuthor": true,
                "prefix": "",
                "firstName": "Brian",
                "middleName": "",
                "lastName": "Safina",
                "suffix": ""
            },
            {
                "id": 2500884,
                "identity": "a1b50f19-6ef5-4990-b36f-aa7db533968a",
                "order_by": 1,
                "name": "Art Lee",
                "email": "",
                "orcid": "",
                "institution": "",
                "correspondingAuthor": false,
                "prefix": "",
                "firstName": "Art",
                "middleName": "",
                "lastName": "Lee",
                "suffix": ""
            }
        ],
        "badges": [],
        "createdAt": "2020-09-10 22:34:55",
        "currentVersionCode": 1,
        "declarations": "",
        "doi": "10.21203/rs.3.pex-1149/v1",
        "doiUrl": "https://doi.org/10.21203/rs.3.pex-1149/v1",
        "draftVersion": [],
        "editorialEvents": [],
        "editorialNote": "",
        "failedWorkflow": [],
        "files": [
            {
                "id": 6570105,
                "identity": "ccfbd93c-211b-4090-80f4-95d737e81666",
                "added_by": "auto",
                "created_at": "2021-03-03 17:20:25",
                "extension": "jpg",
                "order_by": 1,
                "title": "Figure 1",
                "display": "",
                "copyAsset": false,
                "role": "figure",
                "size": 13708,
                "visible": true,
                "origin": "",
                "legend": "Synthetic scheme for T785",
                "description": "",
                "filename": "Schemet785.jpg",
                "url": "https://assets.researchsquare.com/files/pex-1149/v1/21af9f768efb5d550871d7a4.jpg"
            },
            {
                "id": 13674973,
                "identity": "f3008604-a9c7-4f12-947c-fd25683a2a86",
                "added_by": "auto",
                "created_at": "2021-09-17 11:23:53",
                "extension": "pdf",
                "order_by": 0,
                "title": "",
                "display": "",
                "copyAsset": false,
                "role": "manuscript-pdf",
                "size": 132572,
                "visible": true,
                "origin": "",
                "legend": "",
                "description": "",
                "filename": "manuscript.pdf",
                "url": "https://assets.researchsquare.com/files/pex-1149/v1/ee09e4f6-682b-4619-a848-dda9c07f210a.pdf"
            },
            {
                "id": 6570106,
                "identity": "2abb1d45-7752-4162-ad21-6aa7b5e0b8dd",
                "added_by": "auto",
                "created_at": "2021-03-03 17:20:25",
                "extension": "docx",
                "order_by": 1,
                "title": "",
                "display": "",
                "copyAsset": false,
                "role": "supplement",
                "size": 83793,
                "visible": true,
                "origin": "",
                "legend": "Synthesis procedure for T785",
                "description": "",
                "filename": "T785SynthesisNatCancer09102020upload.docx",
                "url": "https://assets.researchsquare.com/files/pex-1149/v1/4bdc4c052fc0eeeecbcdf210.docx"
            }
        ],
        "financialInterests": "",
        "fulltextSource": "",
        "fullText": "",
        "funders": [],
        "hasOptedInToPreprint": true,
        "hasPassedJournalQc": "",
        "hideJournal": true,
        "highlight": "",
        "institution": "",
        "isAuthorSuppliedPdf": false,
        "isDeskRejected": "",
        "isHiddenFromSearch": false,
        "isInQc": false,
        "isInWorkflow": false,
        "journal": {
            "display": true,
            "email": "protocol.exchange@nature.com",
            "identity": "protocol-exchange",
            "isNatureJournal": false,
            "hasQc": false,
            "allowDirectSubmit": true,
            "externalIdentity": "",
            "sideBox": "",
            "submissionUrl": "https://protocolexchange.researchsquare.com/submission",
            "title": "Protocol Exchange",
            "twitterHandle": ""
        },
        "keywords": "T785, chemical synthesis, small molecule, cancer",
        "license": {
            "name": "CC BY 4.0",
            "url": "https://creativecommons.org/licenses/by/4.0/"
        },
        "manuscriptAbstract": "<p>Chemical synthesis procedure and methods for T785 small molecule</p>",
        "manuscriptTitle": "Synthesis of T785",
        "msid": "",
        "msnumber": "",
        "nonDraftVersions": [
            {
                "code": 1,
                "date": "2021-03-03 17:20:23",
                "doi": "10.21203/rs.3.pex-1149/v1",
                "editorialEvents": [
                    {
                        "type": "communityComments",
                        "content": 0
                    }
                ],
                "status": "published",
                "journal": {
                    "display": true,
                    "email": "info@researchsquare.com",
                    "identity": "researchsquare",
                    "isNatureJournal": false,
                    "hasQc": true,
                    "allowDirectSubmit": true,
                    "externalIdentity": "",
                    "sideBox": "",
                    "submissionUrl": "/submission",
                    "title": "Research Square",
                    "twitterHandle": "researchsquare"
                }
            }
        ],
        "origin": "",
        "ownerIdentity": "2520a940-f44a-436a-a128-ce1a2c60edc0",
        "owner": [],
        "postedDate": "March 3rd, 2021",
        "published": true,
        "revision": "",
        "status": "posted",
        "subjectAreas": [
            {
                "id": 551121,
                "name": "Cancer"
            }
        ],
        "tags": [],
        "versionOfRecord": [],
        "versionCreatedAt": "2021-03-03 17:20:23",
        "video": "",
        "vorDoi": "",
        "vorDoiUrl": "",
        "workflowStages": []
    }
}